← All diseases
Cancer
Kidney cancer
Would you like to receive a message when there is new research about kidney cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was investigated — and you receive a notification as soon as new research on Renal cell carcinoma is published. View what Premium costs.
Publications and studies (2186)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular mechanisms and therapeutic targets of traditional Chinese Medicine compounds in renal cell carcinoma: A comprehensive narrative review. (2026/11/15) ♡
- Shiyiwei Shenqi Pian-derived quercetin reactivates apoptosis in clear cell renal cell carcinoma by destabilizing survivin and x-linked inhibitor of apoptosis protein. (2026/09/01) ♡
- [Clinicopathological features and prognostic factors associated with long-term survival (≥5 years) in patients with clear cell renal cell carcinoma and venous tumor thrombus]. (2026/08/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neoantigen cancer vaccines in the mRNA Era: antigen selection, platform engineering, and clinical translation. (2026/08/10) ♡
- Natural History, Tumor Growth Kinetics, and Renal Functional Outcomes of Sporadic Bilateral Multifocal Papillary Renal Cell Carcinoma: A 25-yr Prospective Cohort Study. (2026/08/10) ♡
- Distinct endogenous retroviruses are expressed in mutational subtypes of clear cell renal cell carcinoma and are linked to improved clinical outcomes. (2026/08/10) ♡
- ASO Visual Abstract: Risk-adapted use of adjuvant systemic therapy after nephrectomy for renal cell carcinoma: a population-based study in the post-approval era. (2026/08/10) ♡
- Radiofrequency Ablation for Recurrent Renal Tumors After Partial Nephrectomy: A Retrospective Cohort Study of Technical Considerations and Oncologic Outcomes. (2026/08/09) ♡
- Association of SGLT2 Inhibitor Use with Clinical Outcomes in Patients Receiving Immune Checkpoint Inhibitors: A Pan-Tumor Propensity-Matched Analysis. (2026/08/08) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Everolimus in the Treatment of Tuberous Sclerosis-Associated Renal Cell Carcinoma in a Pediatric Patient: A Case Report. (2026/08/08) ♡
- A Pathology-Based Model for Postoperative Recurrence or Metastasis Prediction and Adjuvant Immunotherapy Implications of Clear-Cell Renal Cell Carcinoma: A Multicenter, Retrospective Study. (2026/08/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Clear Cell Carcinoma of the Left Colon: A Case Report. (2026/08/07) ♡
- Mesenchymal stromal cells regulate M2 macrophage polarization that promotes proliferation, migration, and invasion of renal cell carcinoma cells. (2026/08/07) ♡
- Dissecting a Diagnostic Enigma, Multiple Bilateral Facial Nodules in a Middle Aged Woman. (2026/08/07) ♡
- APOE(+) macrophages and POSTN(+)CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma. (2026/08/07) ♡
- Chronic interferon signaling at baseline is associated with acquired resistance to immunotherapy in metastatic melanoma. (2026/08/07) ♡
- Polymeric mesoscale nanoparticles exhibit dynamin- and macropinocytosis-dependent endocytosis. (2026/08/07) ♡
- Impact of discordance between preoperative MRI and intraoperative ultrasound on surgical strategy in renal cell carcinoma with venous tumour thrombus. (2026/08/07) ♡
- 3D co-culture model of tumor spheroid and endothelial cells unveils ccRCC aberrant vasculature and distinct sensitivity to targeted treatments. (2026/08/07) ♡
- A Case of Cytokine Release Syndrome (CRS) Related to Treatment With Lenvatinib Plus Pembrolizumab for Metastatic Clear Cell Renal Cell Carcinoma. (2026/08/07) ♡
- Deep visual multi-omics profiling links morphology and molecular programs in clear cell renal cell carcinoma. (2026/08/06) ♡
- ImmunoResponse Predictor: a GUI for accurate response prediction to immunotherapy. (2026/08/06) ♡
- Biopsy Versus Clear-Cell Likelihood Score for Diagnosing Clear Cell Renal Cell Carcinoma in Small Renal Masses on MRI: A Propensity Score-Matched Analysis. (2026/08/05) ♡
- Occult metastases detection and impact on management in renal cell carcinoma imaged with [(89)Zr]Zr-girentuximab. (2026/08/05) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. "Renal cell carcinoma, not otherwise specified" is not a sufficient diagnostic classification. (2026/08/05) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. FASTRACK II: Expanding the Role of SABR in Localized Renal Cell Carcinoma. (2026/08/05) ♡
- Deferred Cytoreductive Nephrectomy With Partial Hepatectomy for Giant Renal Cell Carcinoma of the Right Kidney With Extensive Hepatic Invasion: A Case Report in the Era of Systemic Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors. (2026/08/05) ♡
- Structural Genomics Defines PBRM1 Bromodomain Variant Function in ccRCC. (2026/08/05) ♡
- Upper Urinary Tract Carcinoma With Primary Small Cell Neuroendocrine Cancer-Case Report and Review of Literature. (2026/08/05) ♡
- FLCN loss is characterized by SQSTM1/p62 accumulation despite functional autophagy flux in Birt-Hogg-Dubé syndrome-associated kidney cancer. (2026/08/05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Artificial intelligence empowers full-stack histopathological diagnosis and prognosis of renal cell tumor: a multi-center study with external validation. (2026/08/04) ♡
- Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval Era. (2026/08/04) ♡
- Noninvasive differentiation of upper tract urothelial carcinoma and renal cell carcinoma in challenging renal lesions using urinary DNA methylation. (2026/08/04) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Are Biological Doublets the Future of Adjuvant Therapy after surgery for Renal Cell Carcinoma? (2026/08/04) ♡
- Pulmonary metastasectomy in Iceland: Long-term nationwide trends and outcomes. (2026/08/04) ♡
- Unveiling differential gene expression and pathways in clear cell renal cell carcinoma with sarcomatoid transformation. (2026/08/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dosing challenges for chemotherapy and immunotherapy in congenital achondroplasia: a case report and literature review. (2026/08/03) ♡
- Propensity score-matched comparison of survival outcomes between clear cell and non-clear cell renal cell carcinoma in cT1N0M0 disease. (2026/08/03) ♡
- Therapeutic challenges of a renal collision tumour comprising clear cell renal cell carcinoma and metastatic breast carcinoma: a case report. (2026/08/03) ♡
- ATHENA promotes the assembly of the ATP synthase-associated macromolecular complex and cancer progression. (2026/08/03) ♡
- FAPI-negative Papillary Renal Cell Carcinoma With Markedly FAPI-avid Sacral Insufficiency Fracture. (2026/08/03) ♡
- Robotic Partial Nephrectomy for Isthmic RCC in a Horseshoe Kidney With Aberrant Aortic Arterial Supply. (2026/08/03) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. August 2026 Letter to the Editor. (2026/08/03) ♡
- Targeting MMA-induced USP36 methylmalonylation to suppress macrophage polarization and tumor progression in clear-cell renal cell carcinoma. (2026/08/01) ♡
- Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification. (2026/08/01) ♡
- Perioperative Factors Associated with the Conversion of Robotic-Assisted Partial Nephrectomy to Open Partial and Radical Nephrectomy. (2026/08/01) ♡
- Tissue Memory Score captures proximal tubular identity loss and independently stratifies survival in clear cell renal cell carcinoma. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Functional Role of ALKBH5 in Kidney Injury: Insights Into Mechanisms and Therapeutic Potential. (2026/08/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. TFE3-DualNet: An Interpretable Foundation Model-Based Deep Learning Ensemble for Diagnosing TFE3-Rearranged Renal Cell Carcinoma From Whole-Slide Images in a Two-Center Cohort. (2026/08/01) ♡
- RIOK2 Promotes Clear Cell Renal Cell Carcinoma Progression Through Cell Cycle Regulation. (2026/08/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.